Related references
Note: Only part of the references are listed.Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature
Sadie Bennett et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Human herpesvirus-6,-7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19
Francesco Drago et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate
Itsuki Osawa et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
KSHV: Immune Modulation and Immunotherapy
Grant Broussard et al.
FRONTIERS IN IMMUNOLOGY (2020)
Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19
R. Xu et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Herpes zoster in COVID-19-positive patients
Federico Tartari et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
Daniela Calina et al.
IMMUNOLOGIC RESEARCH (2020)
Regulation of KSHV Latency and Lytic Reactivation
Grant Broussard et al.
VIRUSES-BASEL (2020)
Immunosuppressive Drugs and COVID-19: A Review
Tessa S. Schoot et al.
FRONTIERS IN PHARMACOLOGY (2020)
A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
Dawid Maciorowski et al.
SLAS DISCOVERY (2020)
KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions
Nader Kim El-Mallawany et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Expression of PD-1 and PD-Ls in Kaposi's sarcoma and regulation by oncogenic herpesvirus lytic reactivation
Jungang Chen et al.
VIROLOGY (2019)
Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers
Robert Newton et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives
Nader Kim El-Mallawany et al.
PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS (2018)
Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update
Kawalpreet K. Aneja et al.
FRONTIERS IN MICROBIOLOGY (2017)
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS)
Mark N. Polizzotto et al.
CLINICAL INFECTIOUS DISEASES (2016)
CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells
Lu Dai et al.
ONCOTARGET (2016)
High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China
Y. Cao et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: Maintenance of tight latency with efficient reactivation upon induction
Jinjong Myoung et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
Direct Activation of Emmprin and Associated Pathogenesis by an Oncogenic Herpesvirus
Zhiqiang Qin et al.
CANCER RESEARCH (2010)
Kaposi's sarcoma and its associated herpesvirus
Enrique A. Mesri et al.
NATURE REVIEWS CANCER (2010)
Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression
J Vieira et al.
VIROLOGY (2004)
Share Paper
